LYPD3 Antikörper (AA 31-326)
Kurzübersicht für LYPD3 Antikörper (AA 31-326) (ABIN7158599)
Target
Alle LYPD3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 31-326
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Ly6/PLAUR domain-containing protein 3 protein (31-326AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LYPD3 (LY6/PLAUR Domain Containing 3 (LYPD3))
-
Andere Bezeichnung
- LYPD3
-
Hintergrund
-
Background: Supports cell migration. May be involved in urothelial cell-matrix interactions. May be involved in tumor progression.
Aliases: 2310061G07Rik antibody, C4.4A antibody, GPI-anchored metastasis-associated protein C4.4A homolog antibody, GPI-anchored metastasis-associated protein homolog antibody, Ly6/PLAUR domain-containing protein 3 antibody, Lypd3 antibody, LYPD3_HUMAN antibody, Matrigel-induced gene C4 protein antibody, MIG-C4 antibody, SHINC3 antibody
-
UniProt
- O95274
Target
-